{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:20:44Z","timestamp":1791937244913,"version":"4.3.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"vor","delay-in-days":701,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,15]]},"DOI":"10.1093\/infdis\/jiu606","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T00:56:32Z","timestamp":1415148992000},"page":"1279-1287","source":"Crossref","is-referenced-by-count":198,"title":["Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1\/2a Randomized, Placebo-Controlled Study"],"prefix":"10.1093","volume":"211","author":[{"given":"Elchonon M.","family":"Berkowitz","sequence":"first","affiliation":[{"name":"GlaxoSmithKline Vaccines, King of Prussia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Moyle","sequence":"additional","affiliation":[{"name":"Chelsea and Westminster Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Stellbrink","sequence":"additional","affiliation":[{"name":"Infektionsmedizinisches Centrum Hamburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Sch\u00fcrmann","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Pulmonary Medicine, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kegg","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital NHS Trust, The Trafalgar Clinic, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Stoll","sequence":"additional","affiliation":[{"name":"Medizinische Hochschule Hannover, Zentrum Innere Medizin, Klinische Immunologie II, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El Idrissi","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Vaccines, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Oostvogels","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Vaccines, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Heineman","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Vaccines, King of Prussia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Zoster-015 HZ\/su Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"deJesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lalezari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Orkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,3]]},"reference":[{"key":"key\n\t\t\t\t20180328182326_JIU606C1","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20180328182326_JIU606C2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAI.0b013e318266cd3c","article-title":"Herpes zoster among persons living with HIV in the current antiretroviral therapy era","volume":"61","author":"Blank","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328182326_JIU606C3","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/infdis\/166.5.1153","article-title":"Herpes zoster and human immunodeficiency virus infection","volume":"166","author":"Buchbinder","year":"1992","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328182326_JIU606C4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t20180328182326_JIU606C5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0891-5520(05)70312-3","article-title":"Immune responses to varicella-zoster virus","volume":"10","author":"Arvin","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20180328182326_JIU606C6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-011110-130254","article-title":"Pathogenic mechanisms of HIV disease","volume":"6","author":"Moir","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"key\n\t\t\t\t20180328182326_JIU606C7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/653605","article-title":"Zoster vaccine: current status and future prospects","volume":"51","author":"Oxman","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328182326_JIU606C8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/clinids\/21.2.370","article-title":"Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus","volume":"21","author":"Glesby","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328182326_JIU606C9","first-page":"467","article-title":"Herpes zoster and the stage and prognosis of HIV-1 infection","volume":"73","author":"McNulty","year":"1997","journal-title":"Genitourin Med"},{"key":"key\n\t\t\t\t20180328182326_JIU606C10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/168.1.245","article-title":"Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients. Groupe d'Epidemiologie clinique du SIDA en aquitaine","volume":"168","author":"Rogues","year":"1993","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328182326_JIU606C11","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00002030-199510000-00006","article-title":"Herpes zoster, immunological deterioration and disease progression in HIV-1 infection","volume":"9","author":"Veenstra","year":"1995","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328182326_JIU606C12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.qai.0000178408.62675.b0","article-title":"The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era","volume":"40","author":"Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328182326_JIU606C13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/cid\/cit165","article-title":"Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era","volume":"57","author":"Moanna","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328182326_JIU606C14","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/infdis\/168.5.1264","article-title":"Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group","volume":"168","author":"Glesby","year":"1993","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328182326_JIU606C15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2230.1989.tb01978.x","article-title":"Clinical features of human immunodeficiency virus-associated disseminated herpes zoster virus infection--a review of the literature","volume":"14","author":"Cohen","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"key\n\t\t\t\t20180328182326_JIU606C16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0002-9394(14)76690-5","article-title":"Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome","volume":"112","author":"Margolis","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"key\n\t\t\t\t20180328182326_JIU606C17","first-page":"1528","article-title":"Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180328182326_JIU606C18","first-page":"153","article-title":"Recombinant subunit vaccines: potentials and constraints","volume":"121","author":"Clark","year":"2005","journal-title":"Dev Biol (Basel)"},{"key":"key\n\t\t\t\t20180328182326_JIU606C19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2249.2008.03633.x","article-title":"Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors","volume":"152","author":"Malavige","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20180328182326_JIU606C20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0264-410X(93)90382-8","article-title":"Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine","volume":"11","author":"Vafai","year":"1993","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328182326_JIU606C21","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/0264-410X(94)00073-V","article-title":"Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine","volume":"13","author":"Vafai","year":"1995","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328182326_JIU606C22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/infdis\/jit365","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults \u226550 years of age","volume":"208","author":"Chlibek","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328182326_JIU606C23","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2014.01.019","article-title":"Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study","volume":"32","author":"Chlibek","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328182326_JIU606C24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/infdis\/jis497","article-title":"A phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein E subunit vaccine candidate in young and older adults","volume":"206","author":"Leroux-Roels","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328182326_JIU606C25","first-page":"1","article-title":"Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008","volume":"57","author":"Schneider","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20180328182326_JIU606C26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-1702(95)01270-2","article-title":"Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells","volume":"40","author":"Haumont","year":"1996","journal-title":"Virus Res"},{"key":"key\n\t\t\t\t20180328182326_JIU606C27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jviromet.2012.12.013","article-title":"Sampling of herpes zoster skin lesion types and the impact on viral DNA detection","volume":"188","author":"Mols","year":"2013","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20180328182326_JIU606C28","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit candidate vaccine in adult autologous hematopoietic stem-cell transplant recipients","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328182326_JIU606C29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/hv.6.4.10654","article-title":"Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults","volume":"6","author":"Weinberg","year":"2010","journal-title":"Hum Vaccin"},{"key":"key\n\t\t\t\t20180328182326_JIU606C30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/211\/8\/1279\/13806152\/jiu606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T03:52:28Z","timestamp":1522295548000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/211\/8\/1279\/916271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,3]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,11,3]]},"published-print":{"date-parts":[[2015,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiu606","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,4,15]]},"published":{"date-parts":[[2014,11,3]]}}}